This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Wenqiang Li: Innovator in Medicinal Chemistry
Introduction
Wenqiang Li is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative pharmaceutical compounds. His work focuses on addressing critical challenges in drug resistance and efficacy.
Latest Patents
Wenqiang Li holds a patent for a dual-target inhibitory compound that targets SHP2 and CDK4/6. The patent, titled "SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same," presents a novel approach to synthesizing inhibitors that combine these two targets. This invention is crucial as it provides a solution to the issues of drug resistance and poor drug effects associated with existing inhibitors.
Career Highlights
Li is affiliated with China Pharmaceutical University, where he continues to advance his research in medicinal chemistry. His innovative work has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Wenqiang Li has collaborated with notable colleagues, including Xiaoxing Wu and Xiaoyu Chen, to further enhance the impact of his research in the pharmaceutical field.
Conclusion
Wenqiang Li's contributions to medicinal chemistry through his innovative patent demonstrate his commitment to solving complex challenges in drug development. His work is paving the way for future advancements in the treatment of diseases associated with kinase and phosphatase resistance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile